OPTN/SRTR 2021 Annual Data Report: Liver

• Published in: American journal of transplantation Vol. 23; no. 2; pp. S178 - S263
• Main Authors: Kwong, Allison J., Ebel, Noelle H., Kim, W. Ray, Lake, John R., Smith, Jodi M., Schladt, David P., Schnellinger, Erin M., Handarova, Dzhuliyana, Weiss, Samantha, Cafarella, Matthew, Snyder, Jon J., Israni, Ajay K., Kasiske, Bertram L.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2023
• Subjects: Adult; allocation; Child; COVID-19 - epidemiology; distribution; Graft Survival; Humans; Liver Diseases, Alcoholic; Liver Neoplasms; Liver transplant; Liver Transplantation; Living Donors; Pandemics; Tissue and Organ Procurement; Tissue Donors; United States - epidemiology; waiting list; Waiting Lists; United States; Liver transplant; allocation; distribution; waiting list
• DOI: 10.1016/j.ajt.2023.02.006
• ISSN: 1600-6135

In 2021, liver transplant volume continued to grow, with a record 9,234 transplants performed in the United States, 8,665 (93.8%) from deceased donors and 569 (6.2%) from living donors. There were 8,733 (94.6%) adult and 501 (5.4%) pediatric liver transplant recipients. An increase in the number of deceased donor livers corresponded to an increase in the overall transplant rate and shorter waiting times, although still 10.0% of livers that were recovered were not transplanted. Alcohol-associated liver disease was the leading indication for both waitlist registration and liver transplant in adults, outpacing nonalcoholic steatohepatitis, while biliary atresia remained the leading indication for children. Related to allocation policy changes implemented in 2019, the proportion of liver transplants performed for hepatocellular carcinoma has decreased. Among adult candidates listed for liver transplant in 2020, 37.7% received a deceased donor liver transplant within 3 months, 43.8% within 6 months, and 53.3% within 1 year. Pretransplant mortality improved for children following implementation of acuity circle–based distribution. Short-term graft and patient survival outcomes up to 1 year worsened for adult deceased and living donor liver transplant recipients, which is a reversal of previous trends and coincided with the onset of the COVID-19 pandemic in early 2020. Longer-term outcomes among adult deceased donor liver transplant recipients were unaffected, with overall posttransplant mortality rates of 13.3% at 3 years, 18.6% at 5 years, and 35.9% at 10 years. Pretransplant mortality improved for children following implementation of acuity circle–based distribution and prioritization of pediatric donors to pediatric recipients in 2020. Pediatric living donor recipients had superior graft and patient survival outcomes compared with deceased donor recipients at all time points. [Display omitted]